RESULTS OF A LONGITUDINAL REVIEW OF PULMONARY FUNCTION AND SAFETY DATA IN A PHASE IIB CLINICAL PROGRAMME TESTING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) RECEPTOR ANTAGONIST MAVRILIMUMAB FOR TREATMENT OF RHEUMATOID ARTHRITIS (RA)

被引：1

作者：

Burmester, G. ^{[1
]}

Michaels, M. A. ^{[2
]}

Close, D. ^{[3
]}

Godwood, A. ^{[3
]}

Middleton, K. ^{[3
]}

Miranda, P. ^{[4
]}

Vencovsky, J. ^{[5
]}

Kremer, J. ^{[6
]}

McInnes, I. B. ^{[7
]}

Albulescu, M. ^{[3
]}

Weinblatt, M. ^{[8
]}

机构：

[1] Charite Univ Med Berlin, Berlin, Germany

[2] MedImmune, Gaithersburg, MD USA

[3] MedImmune, Cambridge, England

[4] Ctr Estudios Reumatol, Santiago, Chile

[5] Inst Rheumatol, Prague, Czech Republic

[6] Albany Med Coll, Albany, NY 12208 USA

[7] Univ Glasgow, Glasgow, Lanark, Scotland

[8] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1136/annrheumdis-2017-eular.3131

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

FRI0216

引用

页码：564 / 565

页数：2